Search
Search Results
##search.searchResults.foundPlural##
-
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
741PDF: 477HTML: 92 -
Acquired Hemophilia A successfully treated with rituximab
1850PDF: 1094HTML: 1443Figure 1: 151 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4212PDF: 1705HTML: 1095 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4561PDF: 1282HTML: 1888Untitled: 165Untitled: 163 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
1966PDF: 612HTML: 243 -
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
4PDF: 5Suppl. Files: 0HTML: 0 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2112PDF: 1159HTML: 3684 -
Anemia in the elderly: not always what it seems.
3235PDF: 987HTML: 1752Figure 1: 158Figure 1 revised: 163 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3556PDF: 1251HTML: 702Figure 2: 423Figure 1: 3089 -
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
2854PDF: 662HTML: 1918figure 1: 146figure 2: 161 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2488PDF: 1093HTML: 123 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2313PDF: 888HTML: 486 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4295PDF: 871HTML: 1299Table1: 165 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
897PDF: 545Html: 147 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1165PDF: 732HTML: 296 -
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
1863PDF: 1059HTML: 1885Lung computed tomography CT scan image: 183 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3157PDF: 1300HTML: 4104 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1411PDF: 513HTML: 661 -
Osteolytic bone lesions – A rare presentation of AML M6.
1925PDF: 1052HTML: 7899Untitled: 186 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1481PDF: 560HTML: 170 -
SOLITARY PLASMACYTOMA
3751PDF: 2127HTML: 1199fIGURES 1,2: 191 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2555PDF: 913HTML: 3579 -
Pathologic splenic rupture in a patient with follicular lymphoma
1381PDF: 522HTML: 1171rupture: 161







